Latin America Health Times
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Latin America

Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on May 16, 2025

Spectral Medical to Present at the 3rd Annual  H.C. Wainwright BioConnect Investor Conference

Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

PharmaTher Announces FDA Extends Review Period for Ketamine; New Approval Goal Date August 9, 2025

TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a specialty pharmaceutical company focused on ketamine for unmet medical needs, today announced the U.S. Food and Drug …

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., May 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth

QHSLab, Inc. Signals Strategic Debt Restructuring to Strengthen Balance Sheet and Drive Growth

Company in Advanced Discussions to Restructure Convertible Debt and Unlock Shareholder Value Potential Agreement Expected to Improve Financial Flexibility and Reduce Dilution Pressure WEST PALM BEACH, FL, May 16, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “ …

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting

Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference

First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)

RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing …

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …

First Steroid Cycle: Best Steroids for Muscle Growth (Before And After Result), Steroids for Beginners - By CrazyBulk USA

First Steroid Cycle: Best Steroids for Muscle Growth (Before And After Result), Steroids for Beginners - By CrazyBulk USA

New York City, NY, May 16, 2025 (GLOBE NEWSWIRE) -- Initiating the first steroid cycle as a new bodybuilder may be thrilling yet terrifying. Despite all the information and diverse counsel obtainable over the internet, most new bodybuilders are undecided …

Thyroid Support Under Review: Best Thyroid Support Supplements For Thyroid Health & Healthy Thyroid Hormone Production

Thyroid Support Under Review: Best Thyroid Support Supplements For Thyroid Health & Healthy Thyroid Hormone Production

Richmond, Virginia, May 16, 2025 (GLOBE NEWSWIRE) -- The thyroid gland is a little organ in our body but a very fascinating one. It sits at the bottom of every human body‘s neck. The shape of the thyroid line resembles that of a butterfly and its healthy …

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American…

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American…

Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes CMP-SYNGAP-01 administration led to a significant increase in SYNGAP1 protein …

Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting

Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting

Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the RNAfix® platform in CNS diseases Preclinical data showcases first demonstration of systemically …

Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews

Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews

Perth, Western Australia, May 16, 2025 (GLOBE NEWSWIRE) -- Is enlargement and enhancing stamina and performance in bed with the growing age possible? Male health issues such as low stamina, low libido, frequent ejaculation, short performance, low cognitive …

Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick

Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick

AURORA, Colo., May 16, 2025 (GLOBE NEWSWIRE) -- What This Review Will Cover The Underlying Inflammation Behind Neuropathic Pain and How Arialief Targets It The 7-Second Nerve Relief Trick: The actual steps behind using Arialief. Key Ingredient Analysis: …

Merus annonce la publication d’un article sur le mécanisme d’action du pétosemtamab

Merus annonce la publication d’un article sur le mécanisme d’action du pétosemtamab

UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 16 mai 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », « la Société », « nous » ou « notre/nos », une société d’oncologie au stade clinique développant des anticorps …

Merus gibt die Veröffentlichung des Wirkmechanismus von Petosemtamab in der Fachpresse bekannt

Merus gibt die Veröffentlichung des Wirkmechanismus von Petosemtamab in der Fachpresse bekannt

UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, May 16, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, „das Unternehmen“, „wir“ oder „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper und Antikörper-Wirkstoff- …

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service